Diffusion volume (DV) measurement in endometrial and cervical cancer: A new MRI parameter in the evaluation of the tumor grading and the risk classification
CNR Ibb | back to homepage
▲NavBar
Ricerca avanzata▼
Contiene: [X]      Estesa     Autori: [X]  Tipo di lavoro: [X]   Data iniziale: Data finale: [X]      Sede: Affiliazione IBB     
    
[Pulisci modulo]


Diffusion volume (DV) measurement in endometrial and cervical cancer: A new MRI parameter in the evaluation of the tumor grading and the risk classification (623 visite) (PDF privato 170 visite)

Mainenti PP, Pizzuti LM, Segreto S, Comerci M, Fronzo SD, Romano F, Crisci V, Smaldone M, Laccetti E, Storto G, Alfano B, Maurea S, Salvatore M, Pace L

Eur J Radiol (ISSN: 0720-048x), 2016 Jan; 85(1): 113-124.



Tipo di articolo: Journal Article,

Impact factor: 2.462, Impact factor a 5 anni: 2.507

Url: http://dx.doi.org/10.1016/j.ejrad.2015.10.014

Parole chiave: Mri, Dwi, Adc Maps, Diffusion Volume, Cervical Cancer, Endometrial Cancer, Adult, Aged, Article, Automation, Cancer Classification, Cancer Grading, Cancer Risk, Cancer Staging, Diffusion Weighted Imaging, Endometrium Cancer, Female, High Risk Population, Histopathology, Human, Kruskal Wallis Test, Major Clinical Study, Nuclear Magnetic Resonance Imaging, Priority Journal, Receiver Operating Characteristic, Uterine Cervix Cancer, Analysis Of Variance , Diffusion Magnetic Resonance Imaging Methods , Endometrial Neoplasms Pathology , Image Interpretation, Computer-Assisted , Middle Aged , Neoplasm Grading , Observer Variation , Sensitivity And Specificity , Tumor Burden , Uterine Cervical Neoplasms Pathology,

Affiliazioni:

*** IBB - CNR ***
IBB CNR, Napoli, Italy
Dipartimento di Scienze Biomediche Avanzate, Sezione di Radiologia, Università di Napoli “Federico II”, Napoli, Italy
IRCCS CROB, Rionero in Vulture, Italy
IRCCS SDN, Napoli, Italy
Dipartimento di Medicina e Chirurgia, Università degli Studi di Salerno, Salerno, Italy


Riferimenti:

[1] T. Koyama, K. Tamai, K. Togashi, Staging of carcinoma of the uterine cervix and endometrium, Eur. Radiol. 17 (8) (2007) 2009–2019.

[2] G. Rechichi, S. Galimberti, M. Signorelli, P. Perego, M.G. Valsecchi, S. Sironi, Myometrial invasion in endometrial cancer: diagnostic performance of diffusion weighted MR imaging at 1.5-T, Eur. Radiol. 20 (3) (2010) 754–762.

[3] A. Andreano, G. Rechichi, P. Rebora, S. Sironi, M.G. Valsecchi, S. Galimberti, MR 24 (6) (2014) 1327–1338.

[4] H.A. Rowley, P.E. Grant, T.P. Roberts, Diffusion MR imaging: theory and applications, Neuroimaging Clin. N. Am. 9 (2) (1999) 343–361.

[5] D.M. Koh, D.J. Collins, Diffusion-weighted MRI in the body: applications and challenges in oncology, AJR Am. J. Roentgenol. 188 (6) (2007) 1622–1635.

[6] S. Naganawa, C. Sato, H. Kumada, T. Ishigaki, S. Miura, O. Takizawa, Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix, Eur. Radiol. 15 (1) (2005) 71–78.

[7] P.Z. McVeigh, A.M. Syed, M. Milosevic, A. Fyles, M.A. Haiderd,Diffusion-weighted MRI in cervical cancer, Eur. Radiol. 18 (5) (2008) 1058–1064.

[8] E. Sala, A. Rockall, D. Rangarajanc, R.A. Kubik-Huch, The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis, Eur. J. Radiol. 76 (3) (2010) 367–385.

[9] S. Punwani, Diffusion weighted imaging of female pelvic cancers: concepts and clinical applications, Eur. J. Radiol. 78 (1) (2011) 21–29.

[10] G. Rechichi, S. Galimberti, M. Signorelli, C.T. Franzesi, P. Perego, M.G. Valsecchi, et al., Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade, depth of myometrial invasion, and presence of lymph node metastases, AJR Am. J. Roentgenol. 197 (1) (2011) 256–262.

[11] S. Fujii, E. Matsusue, J. Kigawa, S. Sato, Y. Kanasaki, J. Nakanishi, et al., Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: initial results, Eur. Radiol. 18 (2) (2008) 384–389.

[12] S.H. Shen, Y.Y. Chiou, J.H. Wang, M.S. Yen, R.C. Lee, C.R. Lai, et al., echo-planar imaging with parallel technique in assessment of endometrial cancer, AJR Am. J. Roentgenol. 190 (2) (2008)

[13] K. Tamai, T. Koyama, T. Saga, S. Umeoka, Y. Mikami, S. Fujii, et al., Diffusion weighted MR imaging of uterine endometrial cancer, J. Magn. Reson. Imaging 26 (3) (2007) 682–687.

[14] N. Bharwani, M.E. Miquel, A. Sahdev, P. Narayanan, G. Malietzis, R.H. Reznek, et al., Diffusion-weighted imaging in the assessment of tumour grade in endometrial cancer, Br. J. Radiol. 84 (1007) (2011) 997–1004.

[15] Y. Inada, M. Matsuki, G. Nakai, F. Tatsugami, M. Tanikake, I. Narabayashi, et al., Body diffusion weighted MR imaging of uterine endometrial cancer: is it helpful in the detection of cancer in non enhanced MR imaging? Eur. J. Radiol. 70 (1) (2009) 122–127.

[16] K. Cao, M. Gao, Y.S. Sun, Y.L. Li, Y. Sun, Y.N. Gao, et al., Apparent diffusion coefficient of diffusion weighted MRI in endometrial carcinoma-Relationship with local invasiveness, Eur. J. Radiol. 81 (8) (2012) 1926–1930.

[17] P. Beddy, A.C. O’Neil, A.K. Yamamoto, H.C. Addley, C. Reinhold, E. Sala, fiGO staging system for endometrial cancer: added benefits of MR imaging,Radiographics 32 (1) (2012) 241–254.

[18] K. Downey, S.F. Riches, V.A. Morgan, S.L. Giles, A.D. Attygalle, T.E. Ind, et al., Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images, AJR Am. J. Roentgenol. 200 (2) (2013) 314–320.

[19] F. Kuang, J. Ren, Q. Zhong, F. Liyuan, Y. Huan, Z. Chen, The value of apparent diffusion coefficient in the assessment of cervical cancer, Eur. Radiol. 23 (4) (2013) 1050–1058.

[20] R. Bos, J.J. van Der Hoeven, E. van Der Wall, P. van Der Groep, P.J. van Diest, E.F.Comans, et al., Biologic correlates of (18) fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography, J. Clin. Oncol. 20 (2) (2002) 379–387.

[21] T. Higashi, N. Tamaki, T. Torizuka, Y. Nakamoto, H. Sakahara, T. Kimura, et al.,FDG uptake, GLUT-1, glucose transporter and cellularity in human pancreatic tumors, J. Nucl. Med. 39 (10) (1998) 1727–1735.

[22] K. Ito, T. Kato, T. Ohta, et al., fluorine-18 fluoro-2-deoxyglucose positron emission tomography in recurrent rectal cancer: relation to tumour size and cellularity, Eur. J. Nucl. Med. 23 (10) (1996) 1372–1377.

[23] R. Fonti, M. Larobina, S. Del Vecchio, S. De Luca, R. Fabbricini, L. Catalano, et al., Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma, J. Nucl. Med. 53 (12) (2012) 1829–1835.

[24] N. Colombo, E. Preti, F. Landoni, S. Carinelli, A. Colombo, C. Marini, et al., Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow up, Ann. Oncol. 22 (2011) 35–39, Suppl 7: vii.

[25] S.J. Freeman, A.M. Aly, M.Y. Kataoka, H.C. Addley, C. Reinhold, E. Sala, The revised fiGO staging system for uterine malignancies: implications for MR imaging, Radiographics 32 (6) (2012) 1805–1827.

[26] N. Colombo, S. Carinelli, A. Colombo, C. Marini, D. Rollo, C. Sessa, et al., Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann. Oncol. 23 (2012) 27–32, Suppl 7: vii.

[27] A. Berkowitz, S. Basu, S. Srinivas, S. Sankaran, S. Schuster, A. Alavi, Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET, Nucl. Med. Commun. 29 (6) (2008) 521–526.

[28] H.H. Chung, J.W. Kim, K.H. Han, J.S. Eo, K.W. Kang, N.H. Park, et al., Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer, Gynecol. Oncol. 120 (2) (2011) 270–274.

[29] G. Storto, E. Nicolai, M. Salvatore, [18F]FDG-PET-CT for early monitoring of tumor response: when and why, Q. J. Nucl. Med. Mol. Imaging 53 (2) (2009) 167–180.

[30] J.R. Olsen, J. Esthappan, T. DeWees, V.R. Narra, F. Dehdashti, B.A. Siegel, et al., Tumor volume and subvolume concordance between FDG-PET/CT and diffusion-weighted MRI for squamous cell carcinoma of the cervix, J. Magn. Reson. Imaging 37 (2) (2013) 431–434.

[31] H. Sun, J. Xin, S. Zhang, Q. Guo, Y. Lu, W. Zhai, et al., Anatomical and functional volume concordance between FDG PET, and T2 and diffusion-weighted MRI for cervical cancer: a hybrid PET/MR study, Eur. J. Nucl. Med. Mol. Imaging 41 (5) (2014) 898–905.

[32] M. Uhl, U. Saueressig, G. Koehler, U. Kontny, C. Niemeyer, W. Reichardt, et al., Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas, Pediatr. Radiol. 36 (12) (2006) 1306–1311.

[33] M.Y. Choi, K.M. Lee, J.K. Chung, D.S. Lee, J.M. Jeong, J.G. Park, et al., Correlation between serum CEA level and metabolic volume as determined by FDG PET in postoperative patients with recurrent colorectal cancer, Ann. Nucl. Med. 19 (2) (2005) 123–129.

[34] E.H. Dibble, A.C. Alvarez, M.T. Truong, G. Mercier, E.F. Cook, R.M. Subramaniam, 18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging, J. Nucl. Med. 53 (5) (2012) 709–715.

[35] P. Sridhar, G. Mercier, J. Tan, M.T. Truong, B. Daly, R.M. Subramaniam, FDG PET metabolic tumor volume segmentation and pathologic volume of primary human solid tumors, AJR Am. J. Roentgenol. 202 (5) (2014) 1114–1119.

[36] N. Withofs, C. Bernard, C. Van der Rest, P. Martinive, M. Hatt, S. Jodogne, et al., FDG PET/CT for rectal carcinoma radiotherapy treatment planning: comparison of functional volume delineation algorithms and clinical challenges, J. Appl. Clin. Med. Phys. 15 (5) (2014) 4696.

[37] S. Zhang, J. Xin, Q. Guo, J. Ma, Q. Ma, H. Sun, Comparison of tumor volume between PET and MRI in cervical cancer with hybrid PET/MR, Int. J. Gynecol. Cancer 24 (4) (2014) 744–750.

[38] D.M. Lambregts, G.L. Beets, M. Maas, L. Curvo-Semedo, A.G. Kessels, T. Thywissen, et al., Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability, Eur. Radiol. 21 (12) (2011) 2567–2574.

Koyama, T., Tamai, K., Togashi, K., Staging of carcinoma of the uterine cervix and endometrium (2007) Eur. Radiol., 17 (8), pp. 2009-201

Rechichi, G., Galimberti, S., Signorelli, M., Perego, P., Valsecchi, M.G., Sironi, S., Myometrial invasion in endometrial cancer: Diagnostic performance of diffusione weighted MR imaging at 1.5-T (2010) Eur. Radiol., 20 (3), pp. 754-762

Andreano, A., Rechichi, G., Rebora, P., Sironi, S., Valsecchi, M.G., Galimberti, S., MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer: A systematic review and meta-analysis (2014) Eur. Radiol, 24 (6), pp. 1327-1338

Rowley, H.A., Grant, P.E., Roberts, T.P., Diffusion MR imaging: Theory and applications (1999) Neuroimaging Clin. N. Am., 9 (2), pp. 343-361

Koh, D.M., Collins, D.J., Diffusion-weighted MRI in the body: Applications and challenges in oncology (2007) AJR Am. J. Roentgenol., 188 (6), pp. 1622-1635

Naganawa, S., Sato, C., Kumada, H., Ishigaki, T., Miura, S., Takizawa, O., Apparent diffusion coefficient in cervical cancer of the uterus: Comparison with the normal uterine cervix (2005) Eur. Radiol., 15 (1), pp. 71-78

McVeigh, P.Z., Syed, A.M., Milosevic, M., Fyles, A., Haiderd, M.A., Diffusion-weighted MRI in cervical cancer (2008) Eur. Radiol., 18 (5), pp. 1058-1064

Sala, E., Rockall, A., Rangarajanc, D., Kubik-Huch, R.A., The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis (2010) Eur. J. Radiol., 76 (3), pp. 367-385

Punwani, S., Diffusion weighted imaging of female pelvic cancers: Concepts and clinical applications (2011) Eur. J. Radiol., 78 (1), pp. 21-29

Fujii, S., Matsusue, E., Kigawa, J., Sato, S., Kanasaki, Y., Nakanishi, J., Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: Initial results (2008) Eur. Radiol., 18 (2), pp. 384-389

Shen, S.H., Chiou, Y.Y., Wang, J.H., Yen, M.S., Lee, R.C., Lai, C.R., Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer (2008) AJR Am. J. Roentgenol., 190 (2), pp. 481-488

Tamai, K., Koyama, T., Saga, T., Umeoka, S., Mikami, Y., Fujii, S., Diffusion weighted MR imaging of uterine endometrial cancer (2007) J. Magn. Reson. Imaging, 26 (3), pp. 682-687

Bharwani, N., Miquel, M.E., Sahdev, A., Narayanan, P., Malietzis, G., Reznek, R.H., Diffusion-weighted imaging in the assessment of tumour grade in endometrial cancer (2011) Br. J. Radiol., 84 (1007), pp. 997-1004

Inada, Y., Matsuki, M., Nakai, G., Tatsugami, F., Tanikake, M., Narabayashi, I., Body diffusion weighted MR imaging of uterine endometrial cancer: Is it helpful in the detection of cancer in non enhanced MR imaging? (2009) Eur. J. Radiol., 70 (1), pp. 122-127

Cao, K., Gao, M., Sun, Y.S., Li, Y.L., Sun, Y., Gao, Y.N., Apparent diffusion coefficient of diffusion weighted MRI in endometrial carcinoma-Relationship with local invasiveness (2012) Eur. J. Radiol., 81 (8), pp. 1926-1930

Beddy, P., O'Neil, A.C., Yamamoto, A.K., Addley, H.C., Reinhold, C., Sala, E., FIGO staging system for endometrial cancer: Added benefits of MR imaging (2012) Radiographics, 32 (1), pp. 241-254

Downey, K., Riches, S.F., Morgan, V.A., Giles, S.L., Attygalle, A.D., Ind, T.E., Relationship between imaging biomarkers of stage i cervical cancer and poor-prognosis histologic features: Quantitative histogram analysis of diffusion-weighted MR images (2013) AJR Am. J. Roentgenol., 200 (2), pp. 314-320

Kuang, F., Ren, J., Zhong, Q., Liyuan, F., Huan, Y., Chen, Z., The value of apparent diffusion coefficient in the assessment of cervical cancer (2013) Eur. Radiol., 23 (4), pp. 1050-1058

Bos, R., Van Der Hoeven, J.J., Van Der Wall, E., Van Der Groep, P., Van Diest, P.J., Comans, E.F., Biologic correlates of (18) fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography (2002) J. Clin. Oncol., 20 (2), pp. 379-387

Higashi, T., Tamaki, N., Torizuka, T., Nakamoto, Y., Sakahara, H., Kimura, T., FDG uptake, GLUT-1, glucose transporter and cellularity in human pancreatic tumors (1998) J. Nucl. Med., 39 (10), pp. 1727-1735

Ito, K., Kato, T., Ohta, T., Fluorine-18 fluoro-2-deoxyglucose positron emission tomography in recurrent rectal cancer: Relation to tumour size and cellularity (1996) Eur. J. Nucl. Med., 23 (10), pp. 1372-1377

Fonti, R., Larobina, M., Del Vecchio, S., De Luca, S., Fabbricini, R., Catalano, L., Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma (2012) J. Nucl. Med., 53 (12), pp. 1829-1835

Colombo, N., Preti, E., Landoni, F., Carinelli, S., Colombo, A., Marini, C., Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow up (2011) Ann. Oncol., 22, pp. 35-39. , Suppl 7: vii

Freeman, S.J., Aly, A.M., Kataoka, M.Y., Addley, H.C., Reinhold, C., Sala, E., The revised FIGO staging system for uterine malignancies: Implications for MR imaging (2012) Radiographics, 32 (6), pp. 1805-1827

Colombo, N., Carinelli, S., Colombo, A., Marini, C., Rollo, D., Sessa, C., Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2012) Ann. Oncol., 23, pp. 27-32. , Suppl 7: vii

Berkowitz, A., Basu, S., Srinivas, S., Sankaran, S., Schuster, S., Alavi, A., Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: A novel approach with fluorodeoxyglucose-PET (2008) Nucl. Med. Commun., 29 (6), pp. 521-526

Chung, H.H., Kim, J.W., Han, K.H., Eo, J.S., Kang, K.W., Park, N.H., Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer (2011) Gynecol. Oncol., 120 (2), pp. 270-274

Storto, G., Nicolai, E., Salvatore, M., [18F]FDG-PET-CT for early monitoring of tumor response: When and why (2009) Q. J. Nucl. Med. Mol. Imaging, 53 (2), pp. 167-180

Olsen, J.R., Esthappan, J., DeWees, T., Narra, V.R., Dehdashti, F., Siegel, B.A., Tumor volume and subvolume concordance between FDG-PET/CT and diffusion-weighted MRI for squamous cell carcinoma of the cervix (2013) J. Magn. Reson. Imaging, 37 (2), pp. 431-434

Sun, H., Xin, J., Zhang, S., Guo, Q., Lu, Y., Zhai, W., Anatomical and functional volume concordance between FDG PET, and T2 and diffusion-weighted MRI for cervical cancer: A hybrid PET/MR study (2014) Eur. J. Nucl. Med. Mol. Imaging, 41 (5), pp. 898-905

Uhl, M., Saueressig, U., Koehler, G., Kontny, U., Niemeyer, C., Reichardt, W., Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: Preliminary results in osteosarcomas (2006) Pediatr. Radiol., 36 (12), pp. 1306-1311

Choi, M.Y., Lee, K.M., Chung, J.K., Lee, D.S., Jeong, J.M., Park, J.G., Correlation between serum CEA level and metabolic volume as determined by FDG PET in postoperative patients with recurrent colorectal cancer (2005) Ann. Nucl. Med., 19 (2), pp. 123-129

Dibble, E.H., Alvarez, A.C., Truong, M.T., Mercier, G., Cook, E.F., Subramaniam, R.M., 18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: Adding value to clinical staging (2012) J. Nucl. Med., 53 (5), pp. 709-715

Sridhar, P., Mercier, G., Tan, J., Truong, M.T., Daly, B., Subramaniam, R.M., FDG PET metabolic tumor volume segmentation and pathologic volume of primary human solid tumors (2014) AJR Am. J. Roentgenol., 202 (5), pp. 1114-1119

Withofs, N., Bernard, C., Van Der Rest, C., Martinive, P., Hatt, M., Jodogne, S., FDG PET/CT for rectal carcinoma radiotherapy treatment planning: Comparison of functional volume delineation algorithms and clinical challenges (2014) J. Appl. Clin. Med. Phys., 15 (5), p. 4696

Zhang, S., Xin, J., Guo, Q., Ma, J., Ma, Q., Sun, H., Comparison of tumor volume between PET and MRI in cervical cancer with hybrid PET/MR (2014) Int. J. Gynecol. Cancer, 24 (4), pp. 744-750

Lambregts, D.M., Beets, G.L., Maas, M., Curvo-Semedo, L., Kessels, A.G., Thywissen, T., Tumour ADC measurements in rectal cancer: Effect of ROI methods on ADC values and interobserver variability (2011) Eur. Radiol., 21 (12), pp. 2567-2574



<div style="text-align: justify;"><br><i></i><div style="text-align: justify;"><i><i><b>Purpose:</b></i> A new MRI parameter representative of active tumor burden is proposed: diffusion volume (DV), defined as the sum of all the voxels within a tumor with apparent diffusion coefficient (ADC) values within a specific range.<br></i><div style="text-align: justify;">The aims of the study were: (a) to calculate DV on ADC maps in patients with cervical/endometrial cancer; (b) to correlate DV with histological grade (G) and risk classification; (c) to evaluate intra/inter-observer agreement of DV calculation.<br><i></i><div style="text-align: justify;"><i><i><b>Materials and methods:</b></i> Fifty-three patients with endometrial (n = 28) and cervical (n = 25) cancers under-went pelvic MRI with DWI sequences. Both endometrial and cervical tumors were classified on the basis of G (G1/G2/G3) and FIGO staging (low/medium/high-risk).<br></i><div style="text-align: justify;">A semi-automated segmentation procedure was used to calculate the DV. A freehand closed ROI out-lined the whole visible tumor on the most representative slice of ADC maps defined as the slice with the maximum diameter of the solid neoplastic component. Successively, two thresholds were generated on the basis of the mean and standard deviation (SD) of the ADC values: lower threshold (LT = “mean minus three SD”) and higher threshold (HT = “mean plus one SD”). The closed ROI was expanded in 3D, including all the contiguous voxels with ADC values in the range LT-HT × 10–3 mm2/s.<br><div style="text-align: justify;">A Kruskal–Wallis test was used to assess the differences in DV among G and risk groups. Intra-/inter-observer variability for DV measurement was analyzed according to the method of Bland and Altman and the intraclass-correlation–coefficient (ICC).<br><b></b><div style="text-align: justify;"><b><b><i>Results:</i></b><span style="font-weight: 400;"> DV values were significantly different among G and risk groups in both endometrial (p < 0.05) and cervical cancers (p ≤ 0.01). For endometrial cancer, DV of G1 (mean ± sd: 2.81 ± 3.21 cc) neoplasms were significantly lower than G2 (9.44 ± 9.58 cc) and G3 (11.96 ± 8.0 cc) ones; moreover, DV of low risk cancers (5.23 ± 8.0 cc) were significantly lower than medium (7.28 ± 4.3 cc) and high risk (14.7 ± 9.9 cc) ones.</span><br></b><div style="text-align: justify;">For cervical cancer, DV of G1 (0.31 ± 0.13 cc) neoplasms was significantly lower than G3 (40.68 ± 45.65 cc) ones; moreover, DV of low risk neoplasms (6.98 ± 8.08 cc) was significantly lower than medium (21.7 ± 17.13 cc) and high risk (62.9 ± 51.12 cc) ones and DV of medium risk neoplasms was significantly lower than high risk ones.<br><div style="text-align: justify;">The intra-/inter-observer variability for DV measurement showed an excellent correlation for both cancers (ICC ≥ 0.86).<br><b></b><div style="text-align: justify;"><b><b><i>Conclusions:</i></b><span style="font-weight: 400;"> DV is an accurate index for the assessment of G and risk classification of cervical/endometrial cancers with low intra-/inter-observer variability.</span><br></b><br>
Nessun risultato.

Ricerca avanzata▼
Contiene: [X]      Estesa     Autori: [X]  Tipo di lavoro: [X]   Data iniziale: Data finale: [X]      Sede: Affiliazione IBB     
    
[Pulisci modulo]
Vai a fine pagina   Versione per copia e incolla facile   Esporta tutto in BibTeX   Esporta tutto in EndNote


Marr K, Jakimovski D, Mancini M, Carl E, Zivadinov R
* Jugular Venous Flow Quantification Using Doppler Sonography (85 visite)
Ultrasound Med Biol (ISSN: 0301-5629linking), 2018 Aug; 44(8): 1762-1769.
Impact Factor: 2.494
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gallicchio R, Nardelli A, Venetucci A, Capacchione D, Pelagalli A, Sirignano C, Mainenti P, Pedicini P, Guglielmi G, Storto G
* F-18 FDG PET/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer (78 visite)
Eur J Radiol (ISSN: 0720-048x), 2017 Aug; 93: 107-113.
Impact Factor: 2.843
Dettagli    Esporta in BibTeX    Esporta in EndNote

Monti S, Cocozza S, Borrelli P, Straub S, Ladd ME, Salvatore M, Tedeschi E, Palma G
* MAVEN: An Algorithm for Multi-Parametric Automated Segmentation of Brain Veins from Gradient Echo Acquisitions (36 visite) (PDF 122 visite)
Ieee T Med Imaging (ISSN: 0278-0062), 2017; 36(5): 1054-1065.
Impact Factor: 6.131
Dettagli    Esporta in BibTeX    Esporta in EndNote

Neve Polimeno M, Ierano C, D'Alterio C, Simona Losito N, Napolitano M, Portella L, Scognamiglio G, Tatangelo F, Maria Trotta A, Curley S, Costantini S, Liuzzi R, Izzo F, Scala S
* CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not (153 visite)
Cell Mol Immunol (ISSN: 1672-7681), 2014 Nov 3; 12(4): 474-482.
Impact Factor: 4.112
Dettagli    Esporta in BibTeX    Esporta in EndNote

Conson M, Cella L, Pacelli R, Comerci M, Liuzzi R, Salvatore M, Quarantelli M
* Automated delineation of brain structures in patients undergoing radiotherapy for primary brain tumors: From atlas to dose-volume histograms (490 visite) (PDF 296 visite)
Radiother Oncol (ISSN: 0167-8140, 1879-0887), 2014 Sep; 112(3): 326-331.
Impact Factor: 4.363
Dettagli    Esporta in BibTeX    Esporta in EndNote

Zanoli LM, Spoto G
* Isothermal amplification methods for the detection of nucleic acids in microfluidic devices (169 visite)
Biosensors (ISSN: 2079-6374), 2013 Mar; 3(1): 18-43.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mainenti PP, Iodice D, Cozzolino I, Segreto S, Capece S, Sica G, Magliulo M, Ciancia G, Pace L, Salvatore M
* Tomographic imaging of the spleen: the role of morphological and metabolic features in differentiating benign from malignant diseases (146 visite)
Clinical Imaging (ISSN: 1873-4499, 0899-7071), 2012 Sep; 36(5): 559-567.
Impact Factor: 0.648
Dettagli    Esporta in BibTeX    Esporta in EndNote

Scognamiglio PL, Doti N, Grieco P, Pedone C, Ruvo M, Marasco D
* Discovery Of Small Peptide Antagonists Of Ped/Pea15-D4alpha Interaction From Simplified Combinatorial Libraries (214 visite)
Chem Biol Drug Des Chemical Biology And Drug Design (ISSN: 1747-0277, 1747-0285), 2011 May; 77(5): 319-327.
Impact Factor: 2.282
Dettagli    Esporta in BibTeX    Esporta in EndNote

Marasco D, Perretta G, Sabatella M, Ruvo M
* Past and Future Perspectives of Synthetic Peptide Libraries (174 visite)
Curr Protein Pept Sci (ISSN: 1389-2037), 2008 Oct; 9(5): 447-467.
Impact Factor: 3.011
Dettagli    Esporta in BibTeX    Esporta in EndNote

Tedeschi G, Dinacci D, Lavorgna L, Prinster A, Savettieri G, Quattrone A, Livrea P, Messina C, Reggio A, Servillo G, Bresciamorra V, Orefice G, Paciello M, Brunetti A, Paolillo A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Patti F, Salemi G, Cammarata E, Simone I, Salvatore M, Bonavita V, Alfano B
* Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability (209 visite) (PDF 150 visite)
J Neurol Sci (ISSN: 0022-510x), 2007 Dec 15; 263(1-2): 15-19.
Impact Factor: 2.315
Dettagli    Esporta in BibTeX    Esporta in EndNote

Salvati AM, d'Onofrio G, Berti P, Cappabianca MP, Marsili G, De Philippis C, Cossa L, Quarantelli M, Zini G, Mango G
An assessment of the operating characteristics of Coulter Counter model S-Plus STKR (200 visite)
Haematologica (ISSN: 0390-6078, 0006-4971, 0006-6497), 1991 Mar; 76(2): 94-103.
Impact Factor: 2.56
Dettagli    Esporta in BibTeX    Esporta in EndNote



11 Records (11 escludendo Abstract e Conferenze).
Impact factor totale: 30.759 (30.759 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 32.915 (32.915 escludendo Abstract e Conferenze).







    Esporta in BibTeX    Esporta in EndNote

Ultima modifica di Marco Comerci in data Wednesday 20 April 2016, 11:26:57
623 visite. Ultima visita in data Saturday 19 October 2019, 9:06:17